Global biotechs recorded yet another positive quarter, but the fundraising pace did slow down reflecting a comparatively quiet summer period. More than $4 billion was banked by public and private companies in the third quarter of 2013, a 29 percent drop from the almost $6 billion that was raised in the second quarter and 17 percent shy of the total generated in Q1 2013.

Biotech Companies Record Another Positive Quarter | BioWorld
BioWorld Online is the news service of record for the biotechnology industry and is updated every business morning. BioWorld Online will keep you up to date on all of the industry’s business, science and regulatory news — mergers and collaborations, FDA hearings and results, breakthroughs in research and much more.


Comments are closed.